Cargando…
BRCA1 5382insC mutation in sporadic and familial breast and ovarian carcinoma in Scotland.
A restriction site-generating polymerase chain reaction (RG-PCR) assay was developed to detect the BRCA1 5382insC mutation that has been reported in multiple, apparently unrelated breast/ovarian carcinoma families. The assay has been used to screen tumour DNA from 250 breast cancer patients (aged 19...
Autores principales: | Mullen, P., Miller, W. R., Mackay, J., Fitzpatrick, D. R., Langdon, S. P., Warner, J. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228233/ https://www.ncbi.nlm.nih.gov/pubmed/9155062 |
Ejemplares similares
-
Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
por: Mahfoudh, Wijden, et al.
Publicado: (2019) -
Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia
por: Plakhins, Grigorijs, et al.
Publicado: (2011) -
The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine
por: Gorodetska, Ielizaveta, et al.
Publicado: (2015) -
Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil
por: Dillenburg, Crisle Vignol, et al.
Publicado: (2012) -
The NOD2 3020insC Mutation and The Risk of Familial Pancreatic Cancer?
por: Nej, Katarzyna, et al.
Publicado: (2004)